Hepatitis C cure is not reaching overwhelming majority of patients due to financial barriers
Hepatitis C is often referred to as the silent killer because the initial infection has few to no symptoms.
Southwest pilots’ union lays groundwork for potential strike with labor talks at an impasse
Southwest’s pilots’ union is seeking to be released from federal mediation, a step toward a potential strike.
Supreme Court’s Ketanji Brown Jackson blasts affirmative action ruling, clashes with Clarence Thomas
Jackson, a nominee of President Joe Biden, is the high court’s newest justice and the first Black woman to sit on the bench.
Former Pfizer employee charged with insider trading on unreleased Covid pill data
The DOJ said the former employee and his close friend sold their Pfizer call options at “significant profits” totaling more than $350,000.
Minecraft developers quit Reddit after company’s controversial changes
In the latest blow to Reddit after its API billing changes, the makers of Minecraft — one of the best-selling video games of all time — have quit the platform.
Supreme Court rejects affirmative action at colleges as unconstitutional
The Supreme Court ruling on affirmative action at Harvard and the University of North Carolina is a blow to efforts to boost enrollment of racial minorities.
Tech IPO drought reaches 18 months despite Nasdaq’s sharp rebound in first half of 2023
Even with tech stocks rallying this year after a brutal 2022, internet and software companies are steering clear of the IPO market.
First-quarter economic growth was actually 2%, up from 1.3% first reported in major GDP revision
The U.S. economy showed much stronger-than-expected growth in the first quarter than previously thought.
Amazon to soon face big FTC antitrust suit over online marketplace power, report says
The FTC antitrust complaint is expected to focus on Amazon’s online marketplace and could be filed in the coming weeks, Bloomberg reported.
CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older
The CDC said the shots from Pfizer and GSK are expected to be available this fall, when RSV – along with Covid and the flu – begins to spread at higher levels.
